Enzymotec Ltd. to Report First Quarter Fiscal Year 2014 Financial Results

MIGDAL HA'EMEQ, Israel, April 28, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that it will release financial results for the first quarter ended March 31, 2014 on Wednesday, May 14, 2014, before the market opens. Following the release, the Company will host a conference call to discuss these results with additional comments and details. Participating on the call will be Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer.

The conference call is scheduled to begin at 8:30 a.m. ET on Wednesday, May 14, 2014. Listeners in North America may dial 877-359-9508 and international listeners may dial 224-357-2393 along with confirmation code 31406358 to access the live call. A telephonic playback will be available after the call through Wednesday, May 28, 2014. Participants in North America may dial 855-859-2056 and international participants may dial 404-537-3406 along with the confirmation code 31406358 to hear the playback.

The call will also be broadcast live over the Internet, hosted at the Investors section of Enzymotec's website at http://ir.enzymotec.com, and will be archived online within one hour of its completion through Wednesday, May 28, 2014.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies. For more information, visit www.enzymotec.com.

CONTACT: ICR Katie Turner 646-277-1228 Katie.Turner@icrinc.com John Mills 310-954-1105 John.Mills@icrinc.comSource:Enzymotec Ltd.